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A B S T R A C T
OBJECTIVE: Microvolt T-wave alternans (MTWA) was found to be associated with 
cardiac electrical instability. The aim of this study was to investigate the effects of 
biventricular pacing on MTWA in comparison with other pacing modalities.
METHODS: The study group consisted of 50 patients with dilated or ischemic cardio-
myopathy with a cardiac resynchronization therapy device. MTWA was measured 
during several pacing modalities.
RESULTS: Overall, 181 MTWA studies were performed in 50 patients. Seventy-nine 
studies (44%) were negative, 81(45%) were positive and 21 (12%) were indeterminate. 
With right atrial (RA) pacing, 45% of the MTWA tests were negative. With right ven-
tricular (RV) pacing, 30 % were negative, with left ventricular (LV) pacing 44 % were 
negative and with biventricular pacing 52% of the tests were negative (P=0.15). The 
results of TWA testing were concordant between RA pacing and biventricular pacing 
(K=0.46, P=0.007).
CONCLUSION: Microvolt T-wave alternans during biventricular pacing correlates with 
MTWA during atrial pacing and left ventricular pacing.
I N T R O D U C T I O N
Microvolt T-wave alternans (MTWA) measures subtle beat-to-beat variations in 
the T wave during exercise or during rapid atrial pacing. Microvolt T-wave alternans 
was found to be associated with cardiac electrical instability in patients with ischemic 
and dilated cardiomyopathy.1-7 These patients suffer from heart failure and benefit 
from cardiac resynchronization therapy (CRT). There have been conflicting reports 
on the electrical effects of biventricular pacing. Some reports showed a beneficial ef-
fect8 and others showed no effect9 or a detrimental effect with biventricular pacing.10 
The purpose of this study was to systematically measure MTWA in 4 pacing modes 
(right atrial pacing, right ventricular pacing, left ventricular pacing and biventricular 
pacing). Our hypothesis was that a better synchronization of contraction between both 
ventricles may be electrically beneficial.
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M E T H O D S
PA T I E N T  P O P U L A T I O N
The study group consisted of 50 patients with dilated or 
ischemic cardiomyopathy referred to Assaf Harofeh Medical 
Center during the period of August 2003 to October 2009. 
All patients had a left ventricular ejection fraction of <35%. 
All patients underwent a biventricular defibrillator or pace-
maker implantation for treatment of heart failure. Patients 
with atrial fibrillation and patients with atrioventricular (AV) 
block were also included. Patients on antiarrhythmic agents 
and beta blockers were also included and were tested on their 
chronic medications. Informed consent was obtained from all 
study subjects.
M E A S U R E M E N T  O f  M I C R O V O L T  T- wAV E 
A L T E R N A N S
All subjects were prospectively evaluated for MTWA using 
4 different pacing modes via a pacemaker or an implantable 
cardioverter defibrillator (ICD). The patients were paced 
using the AAI mode, DDD mode with right ventricle (RV) 
only, DDD mode with left ventricle (LV) only and DDD 
mode with simultaneous RV and LV pacing. The AV delay 
was programmed at 180 ms. The patients were paced at 110 
beats per minute (bpm) for 5 minutes at each pacing mode. 
After each test the pacing mode was programmed back to bi-
ventricular pacing at the original settings for 10 minutes. The 
HearTwave™ system from Cambridge heart was used (Cam-
bridge Heart Inc., Bedford, MA, USA). The system uses the 
spectral method described by Smith et al.2 After careful skin 
preparation, 7 standard electrodes were placed in the standard 
12-lead position and 7 multi-segment special electrodes were 
arranged in a Frank orthogonal (XYZ) configuration. 
The MTWA test was automatically interpreted within the 
HearTwave™ system and reviewed by a physician. The test was 
considered positive if the alternans voltage was ≥1.9 Volts and 
the alternans ratio was ≥3 for a period of >1 minute in vector 
magnitude (VM), X, Y, Z, or 2 adjacent precordial leads with 
an onset heart rate ≤110 beats/min during pacing. The test was 
considered negative if alternans was absent during a sustained 
interval of pacing at a heart rate of 110 beats/min. If the result 
did not meet the positive or negative criteria, it was considered 
indeterminate. The MTWA results were categorized as nega-
tive and non-negative results (which included the positive and 
indeterminate results) for the purpose of data analysis. 
The patients were seen in the arrhythmia clinic every 6 
months and had their pacemaker or ICD interrogated and the 
device telemetry checked for possible arrhythmias.
S T A T I S T I C A L  A N A Ly S I S
We compared the parameters of patients with a positive 
MTWA and the patients with a negative MTWA. We used 
the chi-square test for the categorical variables and the inde-
pendent sample t–test for the continuous variables. Results 
are presented as mean ± standard deviation. Concordance of 
MTWA test results during RA pacing with pacing from other 
sites was evaluated using the Cohen Kappa test and the Bon-
ferroni post-hoc analysis. Statistical analysis was performed 
using an SPSS version 13 software. A P value of <0.05 was 
considered statistically significant.
R E S U L T S
PA T I E N T  C H A R A C T E R I S T I C S
The clinical characteristics of the 50 patients studied are 
presented in Table 1.
M I C R O V O L T  T- wAV E  A L T E R N A N S  T E S T I N g
Each patient underwent 4 consecutive MTWA studies 
TABLE 1. Patient characteristics
Positive  
MTwA with  
biventricular 
pacing
Negative  
MTwA with  
biventricular  
pacing
P 
value
n=23 n=27
Age (years) 65.4 ± 10.4 66.4.9 ± 11.81 ns
Male, n 20 21 ns
Diagnosis, n
       CAD
       CMP
17
6
18
9
ns
Beta blockers, n 20 27 0.053
Amiodarone therapy, n 7 9 ns
Sotalol therapy, n 3 2 ns
LV electrode site, n
       Lateral wall
       Posterolateral wall
       Epicardial
       Unknown
7
8
2
6
10
12
2
3
ns
ICD Therapy
       NO
       Yes
14
9
20
7
ns
Time from implant to 
MTWA test (ms)
7.46 ± 13.1 11.30 ± 16.75 ns
Follow up from MTWA 
test (ms)
9.78 ± 7.56 13.9 ± 6.70 ns
CAD = coronary artery disease, CMP = cardiomyopathy, ICD = 
implantable cardioverter defibrillator; MWTA = microvolt T-wave 
alternans; ns = non-significant
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using 4 different pacing modes. Overall, 181 MTWA studies 
were performed. Seventy-nine (44%) were negative, 81(45%) 
were positive and 21 (12%) were indeterminate. Nine patients 
had Wenckebach during atrial pacing, 5 patients had atrial 
fibrillation and could not be atrially paced, 3 patients were 
pacemaker dependent and could not be paced in the AAI 
mode and 2 patients did not tolerate rapid LV only pacing 
because of chest discomfort.
With right atrial (RA) pacing, 45% of the MTWA tests 
were negative. With RV pacing, 30 % were negative, with LV 
pacing 44 % were negative and with biventricular pacing 52% 
of the tests were negative (P=0.15). Patients on beta blockers 
were more likely to have a negative MTWA in the biventricular 
pacing mode (P=0.053) (Table 1).
Concordance rates for MTWA were used to compare RA, 
RV and LV pacing to biventricular pacing (Table 2). The re-
sults of MTWA testing were concordant between RA pacing 
and biventricular pacing (K=0.46, P=0.007), and they were 
concordant between LV and biventricular pacing (K=0.50, 
P=0.0001). The results of MTWA were not concordant be-
tween RV pacing and biventricular pacing (K=0.184, P=0.01), 
between LV and RV pacing (K=0.126, P=0.067), between RA 
and RV pacing (K=0.309, P=0.062), and between LV and RA 
pacing (K=0.135, P=0.135).
The data were analyzed also according to the baseline 
QRS morphology prior to device implantation. Thirty pa-
tients had a left bundle branch block (LBBB) and 20 patients 
had a non-LBBB which included right bundle branch block 
(RBBB), non-specific intra-ventricular conduction (IVCD) 
and a narrow QRS complex. Table 3 summarizes the details 
of this analysis. Right ventricular pacing seemed to be more 
detrimental in patients who did not have a LBBB morphology 
on their baseline ECg (P=0.035). 
Two patients died during the follow-up period of 11.7± 
7 months. One patient had a negative MTWA in all 4 pacing 
modes and died from pump failure and the second patient had 
an indeterminate result in all 4 pacing modes and died from a 
ruptured aortic aneurysm. 
TABLE 2. Concordance of MTWA results with the different pacing modes.
RA
N=33
RV
N=50
LV
N=48
Non negative Negative Non negative Negative Non negative Negative
BIV - non negative 12 3 18 5 19 4
BIV - Negative 6 12 16 11 8 17
Concordance 72.7% 58% 79.2%
Kappa K=0.459
P=0.007
K=0.184
P=0.151
K=0.503
P=0.000
BIV = biventricular; LV = left ventricle; MTWA = microvolt T-wave alternans; RA= right atrium; RV= right ventricle. 
TABLE 3. Results of MTWA during the different pacing 
modes in patients with LBBB compared to patients without 
LBBB in their baseline ECg.
LBBB P value
N no yes
BIV - non negative
50
10 13
ns
BIV - Negative 10 17
RA - non negative
33
7 11
ns
RA - Negative 4 11
RV - non negative
50
17 17
0.035
RV - Negative 3 13
LV - non negative
48
11 16
ns
LV - Negative 8 13
BIV = biventricular; ECg = electrocardiogram; LBBB = left bundle 
branch block; LV = left ventricle; MTWA = microvolt T-wave 
alternans; ns = non-significant; RA = right atrium; RV = right ventricle
D I S C U S S I O N
Microvolt T-wave alternans (MTWA) is a relatively new 
noninvasive method for identifying patients at increased risk of 
sudden cardiac death from ventricular arrhythmias.2 It meas-
ures subtle beat to beat fluctuations in the T wave amplitude. 
Microvolt T-wave alternans is heart rate dependent and can 
be measured during an exercise stress test, during pharmaco-
logic stress or during cardiac pacing.11,12 Clinical studies have 
shown a good correlation between MTWA and the results of 
electrophysiological studies in patients with ischemic heart 
disease.2 More recent studies have shown mixed results about 
the capacity of MTWA to predict sudden death, sustained 
ventricular arrhythmias or appropriate ICD discharges.17-21
The present study provides the largest series to date, of 
patients who underwent a MTWA testing during 4 different 
pacing modes. This study indicates that MTWA during bi-
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fIgURE 1. Microvolt T-wave alternans (MTWA) with the 4 different pacing modes in one patient. A= AAI mode, B=DDD mode, 
RV pacing, C= DDD mode, LV pacing, D= DDD mode, RV+LV pacing. LV = left ventric-le(-ular); RV = right ventric-le(-ular).
ventricular pacing correlates with MTWA during right atrial 
pacing and left ventricular pacing but did not correlate with 
MTWA during right ventricular pacing. This suggests that 
biventricular pacing does not have detrimental effects on the 
electrical milieu of the heart whereas; right ventricular pacing 
can be potentially proarrhythmic.
P R E V I O U S  S T U D I E S  O N  M T wA  M E A S U R E M E N T 
A N D  B I V E N T R I C U L A R  PA C I N g
Ehrlich et al studied 30 patients who received cardiac re-
synchronization therapy. In their study there was a high level 
of concordance between MTWA test results during right atrial 
(RA) pacing, right ventricular (RV) pacing, left ventricular 
(LV) pacing and biventricular pacing. They concluded that 
biventricular pacing did not seem to affect the arrhythmogenic 
substrate as detected by MTWA testing.9 The MTWA testing 
protocol included paced heart rates at 80, 90, 100, 110 beats/
min with increments every 180 sec. On the other hand, Anh et 
al studied 33 patients who received cardiac resynchronization 
therapy. In their study, MTWA magnitude was lower during 
biventricular pacing compared to RA, RV or LV pacing. The 
MTWA protocol included pacing at 90, 100, 110, 120 beats/
min, then 110, 100, 90 beats/min changing every 90 seconds. 
They concluded that biventricular pacing attenuates MTWA 
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as compared to the other pacing modes. They also found 
that MTWA during RV pacing predicted arrhythmic events 
more effectively than MTWA with biventricular pacing or 
right atrial pacing.8 From the study of Anh et al, it seems that 
biventricular pacing was superior to right atrial pacing unlike 
our study which showed that MTWA with biventricular pacing 
was comparable to atrial pacing.
Shalaby et al studied MTWA during atrial and ventricular 
pacing.12 Although there was concordance between both tests, 
ventricular pacing generated higher amplitudes and noise and 
a higher percentage of nonnegative results. Similarly, in our 
study, patients with RV pacing were more likely to have a 
non-negative MTWA study.
S T U D y  L I M I T A T I O N S
Microvolt T-wave alternans testing was performed on beta 
blockers and antiarrhythmic agents. There are conflicting data 
in the literature about the need to withhold beta blockers and 
antiarrhythmic agents prior to MTWA testing.5,18-20 Neverthe-
less, patients served as their own control when they underwent 
MTWA testing during the different pacing modes.
We were not able to pace all the patients in the AAI mode 
because of their inability to conduct to the ventricle, or because 
of atrial fibrillation in some patients. The value of MTWA 
pacing in patients with atrial fibrillation who are paced from 
the ventricle is unknown.
C O N C L U S I O N S
Microvolt T-wave alternans during biventricular pacing 
correlates with MTWA during atrial pacing and left ventricu-
lar pacing and does not correlate with MTWA during right 
ventricular pacing in patients with congestive heart failure. 
Biventricular pacing has no detrimental effect on the electrical 
milieu of the ventricles.
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